Business

TherapeuticsMD Completes the Divestiture of vitaCare Prescription Services to GoodRx in a Cash Transaction Valued at $150 Million

BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (NASDAQ: TXMD), (“TXMD” or the “Company”) an innovative, leading women’s healthcare company,

articleTherapeuticsmd, Inc.April 14, 20224/company/therapeuticsmd-inc/news/therapeuticsmd-completes-the-divestiture-of-vitacare-prescription-services-to-goodrx-in-a-cash-transaction-valued-at-dollar150-million
TherapeuticsMD Completes the Divestiture of vitaCare Prescription Services to GoodRx in a Cash Transaction Valued at $150 Million

About this update from Therapeuticsmd, Inc.

[{"type":"text","content":" BOCA RATON, Fla.--(BUSINESS WIRE)--\nTherapeuticsMD, Inc. (NASDAQ: TXMD), (“TXMD” or the “Company”) an innovative, leading women’s healthcare company, announced today the closing of the divestiture of vitaCare Prescription Services to GoodRx (NASDAQ: GDRX), in a cash transaction valued at $150 million, subject to a working capital adjustment. The Company previously announced the signing of a definitive agreement on March 6, 2022. TherapeuticsMD remains eligible to receive an additional $7 million in cash consideration contingent on vitaCare’s financial performance through 2023. With this divestiture, TherapeuticsMD streamlines its operations to focus solely on its women’s health portfolio and serving its mission of empowering women of all ages through better and affordable healthcare.\n\n“We are pleased to complete the sale of vitaCare Prescription Services. This transaction represents the continued execution of our strategy as we remain focused on investing in our key business areas and delivering enhanced value for our patients and shareholders,” said Hugh O’Dowd, Chief Executive Officer of TherapeuticsMD.\n\nAdvisors\n\nLocust Walk served as financial advisor and DLA Piper LLP (US) served as legal counsel to TherapeuticsMD.\n\nAbout TherapeuticsMD, Inc.\n\nTherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. TherapeuticsMD’s products are designed to address the unique changes and challenges women experience through the various stages of their lives with a therapeutic focus in family planning, reproductive health, and menopause management. TherapeuticsMD is committed to advancing the health of women and championing awareness of their healthcare issues. To learn more about TherapeuticsMD, please visit therapeuticsmd.com or follow us on Twitter: @TherapeuticsMD and on Facebook: TherapeuticsMD.\n\nForward-Looking Statements\n\nThis press release by TherapeuticsMD, Inc. may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to TherapeuticsMD’s objectives, plans and strategies as well as statements, other than historical facts, that address activities, events or developments that the company intends, expects, projects, believes or anticipates will or may occur in the fut...

More updates from Therapeuticsmd, Inc.